FDA Approved: PERTZYE — Supplemental Application (Digestive Care, Inc.)

View source ↗

Summary

FDA approved a supplemental application for PERTZYE (pancrelipase) from Digestive Care, Inc., approving changes to the product's labeling. PERTZYE is used to tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Exocrine Pancreatic Insufficiency
• Pancreatitis

Drugs mentioned

• PERTZYE (PANCRELIPASE)

Snippet

SUPPL AP for PERTZYE (PANCRELIPASE)